Deutsche Bank lowers its price target on Brightpoint (Nasdaq: CELL) from $16 to $12.50, but maintains a Buy rating.
This article: 100 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE